Molecular pathology and its relevance to thyroid FNA

David Poller, Sharon Glaysher

Research output: Contribution to journalLiterature reviewpeer-review

283 Downloads (Pure)


This review summarises molecular pathological techniques applicable to thyroid FNA. The molecular pathology of thyroid tumours is now fairly well understood. Molecular methods may be used as a rule-in test for diagnosis of malignancy in thyroid nodules e.g. BRAF V600E point mutation, use of a 7 gene mutational panel (BRAF V600E, RAS genes, RET/PTC or PAX8/PPARG rearrangement), or as a comprehensive multigene next-generation sequencing panel e.g. ThyroSeq v2. Molecular methods can also be applied as rule-out tests for malignancy in thyroid nodules e.g. Afirma or ThyroSeq v2 or as markers of prognosis e.g. TERT promoter mutation or other gene mutations including BRAF V600E, TP53 & AKT1 and as tests for newly defined tumour entities such as NIFTP, or as a molecular marker(s) for targeted therapies. This review describes practical examples of molecular techniques as applied to thyroid FNA in routine clinical practice.
Original languageEnglish
Pages (from-to)475-481
Number of pages7
Issue number6
Early online date22 Nov 2017
Publication statusPublished - 1 Dec 2017


  • diagnosis
  • fine-needle aspiration
  • molecular
  • neoplasms
  • pathology
  • thyroid


Dive into the research topics of 'Molecular pathology and its relevance to thyroid FNA'. Together they form a unique fingerprint.

Cite this